Skip to content
Clinical Trials – home
Verifiedinfo

KRH Klinikum Siloah

Germany Stadionbrücke 4, 30459 Hanover, Germany

  • 3 trials recruiting
  • Irritable bowel syndrome · Acute lymphocytic leukaemia · Acute myeloid leukaemia
  • Adult patients

About Specializations

KRH Klinikum Siloah in Hanover, Germany specialises in clinical trials of conditions such as Irritable bowel syndrome, Acute lymphocytic leukaemia, Acute myeloid leukaemia, Non-small cell lung cancer, and other specialisations. This site conducts important research.

Main research areas of the site

Hematologic Oncology

The medical center is at the forefront of hematologic oncology, focusing on innovative treatments for blood cancers. The center's research is particularly concentrated on acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) with excess blasts.

  • Acute Myeloid Leukemia (AML)
  • Myelodysplastic Syndrome (MDS) with Excess Blasts

Through rigorous clinical trials, the center is exploring the efficacy of novel therapeutic combinations, such as the integration of venetoclax with standard chemotherapy regimens, aiming to enhance event-free survival rates in newly diagnosed patients.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Stadionbrücke 430459 HanoverGermany
Recruiting now
3 trials
Conditions studied
4
Partner status
Verified

More sites in HanoverGermany

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

4 clinical trials

Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Coffee Charcoal
  • Sponsor:REPHA GmbH Biologische Arzneimittel
Countries:GermanyGermany
  • Participants:18–64 years
  • Substances:Blinatumomab
  • Sponsor:Goethe University Frankfurt
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Cytarabine
  • Sponsor:Universitaetsklinikum Ulm AöR
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Alectinib
  • Sponsor:Frankfurter Institut Fuer Klinische Krebsforschung IKF GmbH
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.